ADRB2 polymorphism Arg16Gly modifies the natural outcome of heart failure and dictates therapeutic response to β-blockers in patients with heart failure.
Huang J, Li C, Song Y, Fan X, You L, Tan L, Xiao L, Li Q, Ruan G, Hu S, Cui W, Li Z, Ni L, Chen C, Woo AY, Xiao RP, Wang DW.
Huang J, et al. Among authors: li c, li z, li q.
Cell Discov. 2018 Oct 23;4:57. doi: 10.1038/s41421-018-0058-6. eCollection 2018.
Cell Discov. 2018.
PMID: 30374408
Free PMC article.